Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? is a paper indexed in PICO Portal from OpenAlex.
How many citations does Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? have?
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? has 70 citations in the OpenAlex counts PICO Portal stores.
When was Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? published?
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? has 2020 year in the PICO Portal index.
What is the open-access status of Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown??
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? has hybrid oa status in the PICO Portal index.
What is the DOI of Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown??
The DOI for Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? is on the source record.
What is the PMID of Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown??
The PMID for Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? is on the source record.
What is the OpenAlex record for Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown??
The OpenAlex for Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? is on the source record.